BPI 2026 · CDMO & CRO

Novalix at BPI 2026

Strasbourg, France

Novalix brings 4 presentations to BPI 2026 in Boston. Its appearances sit on the manufacturing strategy track and in the discussion of pain points shared between upstream and downstream processes. Its own services cover the discovery and preclinical stages that precede that work.

OrganizationBPI 2026 Attendance
Novalix
Strasbourg, France
1 Life Sciences Commercial Executive
CDMO & CRO
Preclinical contract research organization offering medicinal chemistry, protein production, structural biology, biophysics and DMPK services.
Chair
Thu Sep 24
11:25am–11:30am
Chairperson Remarks
CMC Strategy & Manufacturing Performance
Chair
Thu Sep 24
2:10pm–2:15pm
Chairperson's Remarks
CMC Strategy & Manufacturing Performance
Talk
Fri Sep 25
2:30pm–3:30pm
PANEL DISCUSSION: Shared Pain Points Between Upstream and Downstream Processes
Cell Culture & Upstream Processing · with AstraZeneca, Merck, LumaCyte +2 more
Talk
Fri Sep 25
2:30pm–3:30pm
Room 312: PANEL DISCUSSION: Shared Pain Points Between Upstream and Downstream Processes
Downstream Processing · with AstraZeneca, Merck, LumaCyte +2 more

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Novalix

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction